Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q4 | $127.1M | -- | -- | $0.81 | -- |
| 11/10/2025 | Q3 | $125.2M | $126M | -$1.16 | $0.80 | -$1.97 |
| 08/05/2025 | Q2 | $121.8M | $123.3M | $0.68 | $0.79 | -$0.11 |
| 05/08/2025 | Q1 | $119.3M | $118.6M | $0.70 | $0.77 | -$0.08 |
| 02/12/2025 | Q4 | $115.1M | $117.3M | $0.67 | $0.75 | -$0.08 |
| 11/12/2024 | Q3 | $108.7M | $112.3M | $0.66 | $0.69 | -$0.03 |
| 08/01/2024 | Q2 | $101.3M | $102.6M | $0.62 | $0.64 | -$0.02 |
| 05/09/2024 | Q1 | $93.5M | $97M | $0.50 | $0.57 | -$0.06 |
| 02/20/2024 | Q4 | $88M | $88.7M | $0.42 | $0.53 | -$0.10 |
| 11/14/2023 | Q3 | -- | $80.5M | $0.45 | -- | -- |
| 07/31/2023 | Q2 | -- | $73.8M | $0.42 | -- | -- |
| 05/10/2023 | Q1 | -- | $72.5M | $0.36 | -- | -- |
| 02/16/2023 | Q4 | -- | $82.2M | $0.45 | -- | -- |
| 11/17/2022 | Q3 | -- | $82M | $0.43 | -- | -- |
| 07/27/2022 | Q2 | -- | $79.6M | $0.43 | -- | -- |
| 05/12/2022 | Q1 | -- | $77.2M | $0.38 | -- | -- |
| 02/10/2022 | Q4 | -- | $74.2M | $0.28 | -- | -- |
| 10/27/2021 | Q3 | -- | $70.7M | $0.41 | -- | -- |
| 08/04/2021 | Q2 | -- | $67.5M | $0.35 | -- | -- |
| 04/28/2021 | Q1 | -- | $57.4M | $0.30 | -- | -- |
| 02/09/2021 | Q4 | -- | $48.6M | $0.18 | -- | -- |
| 10/27/2020 | Q3 | -- | $40.1M | $0.15 | -- | -- |
| 08/05/2020 | Q2 | -- | $37M | $0.13 | -- | -- |
| 05/11/2020 | Q1 | -- | $30.2M | $0.07 | -- | -- |
| 02/20/2020 | Q4 | -- | $33.2M | $0.12 | -- | -- |
| 11/07/2019 | Q3 | -- | $32.5M | $0.11 | -- | -- |
| 08/06/2019 | Q2 | -- | $34.3M | $0.16 | -- | -- |
| 05/06/2019 | Q1 | -- | $34M | $0.16 | -- | -- |
| 02/13/2019 | Q4 | -- | $33.2M | $0.16 | -- | -- |
| 10/31/2018 | Q3 | -- | $32.3M | $0.14 | -- | -- |
| 07/31/2018 | Q2 | -- | $30.5M | $0.12 | -- | -- |
| 05/02/2018 | Q1 | -- | $27.3M | $0.10 | -- | -- |
| 02/07/2018 | Q4 | -- | $25.8M | $0.08 | -- | -- |
| 11/07/2017 | Q3 | -- | $23.8M | $0.32 | -- | -- |
| 08/03/2017 | Q2 | -- | $22.7M | -$0.11 | -- | -- |
| 05/09/2017 | Q1 | -- | $21.1M | $0.09 | -- | -- |
| 02/08/2017 | Q4 | -- | $21.5M | $0.07 | -- | -- |
| 11/07/2016 | Q3 | -- | $21M | $0.03 | -- | -- |
| 07/21/2016 | Q2 | -- | $19.8M | $0.04 | -- | -- |
| 05/05/2016 | Q1 | -- | $24.5M | $0.00 | -- | -- |
| 02/11/2016 | Q4 | -- | $25.8M | -$0.34 | -- | -- |
Camtek Ltd. reported $126M worth of top line sales in its most recent quarter.
Camtek Ltd. announced earnings per share of -$1.16 which represents a miss of analyst forecast a $0.80 per share.
Camtek Ltd. reported $63M that represents $1.38 per share over the last quarter.
Camtek Ltd.'s earnings are forecast to grow from $2.42 per share to $2.79 per share next year representing an increase of 32.11%.
Camtek Ltd.'s next earnings date is February 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.